Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in LUNG — Pulmonx Corp

CIK 1115418 BOSTON, MA
Back to LUNG Full portfolio

Position in LUNG

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$25,197
-$34,633 QoQ
Shares Held
19,383
-58.2% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 107 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LUNG Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,271,214,892 across 85 Medical Devices names. LUNG ranks #83 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 2,820,543 $255,936,071
2 SYK
Stryker Corp
 616,745 $194,175,995
3 MDT
Medtronic plc
 2,213,044 $173,126,432
4 BSX
Boston Scientific Corp
 2,641,843 $112,753,859
5 EW
Edwards Lifesciences Corp
 1,096,770 $99,213,814
6 DXCM
Dexcom Inc
 768,165 $51,735,912
7 GEHC
GE HealthCare Technologies Inc.
 755,006 $48,327,934
8 STE
STERIS plc
 217,541 $45,807,608

All Filings in LUNG

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,197 19,383
2026-03-31 $59,830 46,380
2025-12-31 $124,292 56,241
2025-09-30 $95,814 59,145
2025-06-30 $144,161 55,661
2025-03-31 $376,597 55,958
2024-12-31 $363,285 53,503
2024-09-30 $422,914 51,015
2024-06-30 $327,816 51,706
2024-03-31 $487,991 52,642
2023-12-31 $649,077 50,908
2023-09-30 $505,457 48,931
2023-06-30 $657,545 50,156
2023-03-31 $506,342 45,290
2022-12-31 $368,450 43,707
2022-09-30 $705,434 42,343
2022-06-30 $577,760 39,250
2022-03-31 $662,451 26,701
2021-12-31 $804,443 25,084
2021-09-30 $920,728 25,590
2021-06-30 $1,074,013 24,343
2021-03-31 $574,265 12,555
2020-12-31 $803,185 11,637